APPLIED MOLECULAR EVOLUTION, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 13242
 
  
 
C07K PEPTIDES 10126
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2003/0153,062 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useDec 20, 01Aug 14, 03[C07H, A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9631016 Pen-injector device containing anti-IL-6 antibodiesApr 19, 16Apr 25, 17[A61K, C07K]
9340613 Anti-IL-6 antibodies, compositions, methods and usesDec 04, 13May 17, 16[A61K, C07K]
8623362 Anti-IL-6 antibodiesJun 15, 12Jan 07, 14[A61K]
8623365 Aβ binding moleculesDec 21, 11Jan 07, 14[A61K]
RE43672 Anti-IL-6 antibodies, compositions, methods and usesJul 08, 11Sep 18, 12[A61K, C12N, C07K]
8226611 Anti-IL-6 antibodies, compositions, methods and usesOct 27, 11Jul 24, 12[A61K, C07K, A61M]
8153125 CD20 binding moleculesMay 20, 04Apr 10, 12[A61K, C07K]
8105597 Aβ binding moleculesJul 17, 09Jan 31, 12[A61K, C07K]
8067003 Methods of treating conditions using anti-IL-6 antibodiesOct 08, 10Nov 29, 11[A61K]
7714120 Humanized anti-IL-1 beta antibodiesApr 23, 09May 11, 10[C07H, C12P, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0166,755 ANTI-EGFR ANTIBODIESAbandonedMar 12, 10Jul 01, 10[A61K, C07H, C12N, A61P, C07K]
7723484 Anti-EGFR antibodiesExpiredNov 06, 06May 25, 10[C07K]
7667007 αvβ3-specific antibodiesExpiredApr 14, 08Feb 23, 10[C07K]
2009/0202,986 METHODS OF OPTIMIZING ANTIBODY VARIABLE REGION BINDING AFFINITYAbandonedOct 28, 04Aug 13, 09[C12Q]
7422744 Methods of treating cancer with alphavbeta3-specific antibodiesExpiredMay 30, 03Sep 09, 08[A61K]
7422745 Methods of treating cancer with .sub.v.alpha..beta..sub.3-specific antibodiesExpiredJun 16, 03Sep 09, 08[A61K]
2008/0213,281 Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic AgentsAbandonedDec 04, 03Sep 04, 08[A61K, C07H, C12N, C07D, A61P]
7371382 Methods of inhibiting .alpha..sub.v.beta..sub.3-mediated binding with .alpha..sub.v.beta..sub.3-specific antibodiesExpiredNov 25, 02May 13, 08[A61K]
2008/0089,892 Fc Region VariantsAbandonedJan 10, 05Apr 17, 08[A61K, A61P, C07K]
7115716 Tumor specific monoclonal antibodiesExpiredNov 19, 02Oct 03, 06[C07K]
7070973 Butyrylcholinesterase variants and methods of useExpiredDec 26, 00Jul 04, 06[A61K]
7049121 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useExpiredDec 20, 02May 23, 06[C12N]
6989261 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of useExpiredApr 11, 03Jan 24, 06[C12N]
2005/0136,044 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agentsAbandonedDec 04, 03Jun 23, 05[A61K, C07H, C12P, C12N]
2005/0069,554 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of useAbandonedOct 05, 04Mar 31, 05[A61K, C07H, C12P, C07K]
2005/0003,384 Surface expression libraries of heteromeric receptorsAbandonedJan 28, 04Jan 06, 05[C12Q, C12N, G01N]
2005/0003,469 Tumor specific human monoclonal antibodies and methods of useAbandonedAug 02, 04Jan 06, 05[G01N, C07K]
6787638 Tumor specific human monoclonal antibodies and methods of useExpiredDec 02, 98Sep 07, 04[C07K]
2004/0161,802 Methods for producing and improving therapeutic potency of binding polypeptidesAbandonedFeb 26, 04Aug 19, 04[G01N, C07K]
2004/0162,413 Methods of optimizing antibody variable region binding affinityAbandonedOct 30, 03Aug 19, 04[C12N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.